Built on MVE’s legacy SC 4/2V and 4/3V vapor shipper platform, the next-generation SC 4/2V and 4/3V models have been ...

Dr. Richard Philipson has been appointed Chief Medical Officer (CMO) of Hansa Biopharma AB, effective July 14.

Celltrion USA announced that Stoboclo (denosumab-bmwo) and Osenvelt (denosumab-bmwo), biosimilars referencing Prolia ...

Centauri Therapeutics Limited, an immunotherapy company, has appointed Dr. Debra Barker as Chief Medical Officer (CMO).

Vital Statistics:Year Founded: 1988Number of Employees: 1600Number of Facilities: 12 Who We Are:PLD Pharma Services focuses on the development, manufacturing and packing of small molecule, liquid and ...

We produce aseptically prefilled syringes, cartridges, vials and dual-chamber systems as a globally operating CDMO partner. We are a family-owned, independent company rooted in 75+ years of history.

This is Merck’s anti-PD-1 therapy, for the treatment of adult patients with resectable locally advanced head and neck squamous cell carcinoma (HNSCC) whose tumors express PD-L1 (Combined Positive ...

Cellular Origins has successfully shown that its platform is able to fully automate cell therapy manufacturing processes using validated, off-the-shelf third-party instruments in combination with ...

Together, the companies will evaluate the feasibility of developing targeted radioligand therapies (RLTs) using Debiopharm’s proprietary AbYlink conjugation technology for Alkyon’s modular antibody ...

The new, fully operational Kilo scale GMP facility will serve increased customer demand for advanced materials for use in human clinical trials. This investment enables GL CHEMTEC to bridge the gap ...

RyboDyn, Inc., a biotechnology company pioneering immunotherapies targeting the dark proteome, has been selected to join Lilly Gateway Labs (LGL) in San Diego, an innovation hub operated with ...

AstraZeneca has entered a strategic research collaboration with China’s CSPC Pharmaceuticals Group Limited, focusing on the discovery and development of novel oral drug candidates for various chronic ...